Millennium Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Millennium Management’s Portfolio YTEN Stock Details YTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,364	Closed	-$7.86K	–	6785
2023 Q4	$7.86K	Sell	1,364 -939	-41%	-$6.24K	﹤0.01%	5770
2023 Q3	$18.1K	Buy	+2,303	New	+$57.9K	﹤0.01%	5674
2023 Q1	–	Sell	-498	Closed	-$20K	–	7062
2022 Q4	$20K	Sell	498 -730	-59%	-$43.5K	﹤0.01%	6052
2022 Q3	$88K	Sell	1,228 -1,221	-50%	-$82.4K	﹤0.01%	6010
2022 Q2	$132K	Buy	+2,449	New	+$173K	﹤0.01%	5825
2022 Q1	–	Sell	-2,112	Closed	-$249K	–	7705
2021 Q4	$249K	Sell	2,112 -224	-10%	-$29.5K	﹤0.01%	5721
2021 Q3	$340K	Sell	2,336 -77	-3%	-$12.9K	﹤0.01%	5726
2021 Q2	$494K	Sell	2,413 -440	-15%	-$97.9K	﹤0.01%	5322
2021 Q1	$859K	Buy	+2,853	New	+$965K	﹤0.01%	4359

Other funds holding YTEN

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GWM

Grand Wealth Management Grand Rapids, Michigan $212M AUM 18.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's YTEN Position: Q1 2024 in Review

Millennium Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2024, closing a stake of 1,364 shares — an estimated $7.86K sold.

Millennium Management first reported a position in YTEN in Q1 2021 and held it in 9 quarters. The position peaked at $859K in Q1 2021. 19 funds tracked by Wall St. Rank hold YTEN as of Q1 2024.

Millennium Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 1,364 Yield10 Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $7.86K.
Millennium Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Millennium Management's Yield10 Bioscience, Inc. Common Stock position peaked at $859K in Q1 2021.
19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.